(INFY) Infosys - NYSE
Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 47.369m USD | Total Return: -38.2% in 12m
Avg Turnover: 226M
EPS Trend: 87.5%
Qual. Beats: 1
Rev. Trend: 97.7%
Qual. Beats: -1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Infosys Limited (NYSE: INFY) is an India-headquartered global provider of consulting, technology, outsourcing, and digital services, operating within the IT Consulting & Other Services segment of the Information Technology sector. The company serves clients across more than 30 industries, including financial services, healthcare, manufacturing, retail, and energy, reflecting the broad-based client diversification typical of large-scale Indian IT services firms.
Its service portfolio spans digital transformation, data analytics, applied and generative AI, cloud computing, cybersecurity, enterprise application solutions (Oracle, SAP, Salesforce), and industry-specific platforms. Flagship offerings include Topaz, an AI-first services suite built on generative AI technologies, and Finacle, a widely deployed core banking solution used by banks globally.
Beyond services, Infosys maintains a portfolio of proprietary digital platforms such as Panaya, Infosys Wingspan, and the Infosys Meridian and Cortex suites, and operates the Infosys McCamish insurance platform. The company holds strategic collaborations with Anthropic PBC, Intel, and Harness Inc., supporting its push into AI and developer productivity tooling.
Founded in 1981 and headquartered in Bengaluru, Infosys was originally incorporated as Infosys Technologies Limited and adopted its current name in June 2011. Its ADR trades on the NYSE following a March 1999 listing, and it remains one of the largest publicly listed Indian IT services exporters.
- BFSI segment revenue grows on US bank IT spending recovery
- Generative AI deal momentum accelerates via Topaz platform and Anthropic partnership
- Wage inflation and visa costs pressure operating margins
| Net Income: 3.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA -1.13 > 1.0 |
| NWC/Revenue: 26.77% < 20% (prev 32.42%; Δ -5.65% < -1%) |
| CFO/TA 0.25 > 3% & CFO 4.04b > Net Income 3.31b |
| Net Debt (-2.79b) to EBITDA (4.64b): -0.60 < 3 |
| Current Ratio: 1.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.00b) vs 12m ago -3.75% < -2% |
| Gross Margin: 30.16% > 18% (prev 30.46%; Δ -0.30% > 0.5%) |
| Asset Turnover: 119.0% > 50% (prev 110.6%; Δ 8.41% > 0%) |
| Interest Coverage Ratio: 86.01 > 6 (EBIT TTM 4.08b / Interest Expense TTM 47.5m) |
| A: 0.33 (Total Current Assets 10.9b - Total Current Liabilities 5.52b) / Total Assets 16.4b |
| B: 0.82 (Retained Earnings 13.5b / Total Assets 16.4b) |
| C: 0.24 (EBIT TTM 4.08b / Avg Total Assets 16.9b) |
| D: 1.48 (Book Value of Equity 9.79b / Total Liabilities 6.61b) |
| Altman-Z'' = 8.00 = AAA |
| DSRI: 1.09 (Receivables 6.19b/5.42b, Revenue 20.2b/19.3b) |
| GMI: 1.01 (GM 30.46% / 30.16%) |
| AQI: 0.94 (AQ_t 0.21 / AQ_t-1 0.23) |
| SGI: 1.05 (Revenue 20.2b / 19.3b) |
| TATA: -0.04 (NI 3.31b - CFO 4.04b) / TA 16.4b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of June 24, 2026, the stock is trading at USD 10.79 with a total of 34,589,274 shares traded. Over the past week, the price has changed by -6.98%, over one month by -8.75%, over three months by -17.12% and over the past year by -38.18%.
Current recommended Stop Loss: 10.10 (which is 6.4% or 1.3 ATR below the current price).
Infosys has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold INFY.
- StrongBuy: 4
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.7 | 36.1% |
P/E Trailing = 14.625
P/E Forward = 14.3266
P/S = 2.3499
P/B = 4.8405
P/EG = 2.0771
Revenue TTM = 20.2b USD
EBIT TTM = 4.08b USD
EBITDA TTM = 4.64b USD
Long Term Debt = 634.0m USD (estimated: total debt 967.0m - short term 333.0m)
Short Term Debt = 333.0m USD (from shortTermDebt, last quarter)
Debt = 967.0m USD (from shortLongTermDebtTotal, last quarter) (leases 967.0m already included)
Net Debt = -2.79b USD (calculated: Debt 967.0m - CCE 3.75b)
Enterprise Value = 44.6b USD (47.4b + Debt 967.0m - CCE 3.75b)
Interest Coverage Ratio = 86.01 (Ebit TTM 4.08b / Interest Expense TTM 47.5m)
EV/FCF = 11.94x (Enterprise Value 44.6b / FCF TTM 3.73b)
FCF Yield = 8.37% (FCF TTM 3.73b / Enterprise Value 44.6b)
FCF Margin = 18.52% (FCF TTM 3.73b / Revenue TTM 20.2b)
Net Margin = 16.44% (Net Income TTM 3.31b / Revenue TTM 20.2b)
Gross Margin = 30.16% ((Revenue TTM 20.2b - Cost of Revenue TTM 14.1b) / Revenue TTM)
Gross Margin QoQ = 30.85% (prev 28.22%)
Tobins Q-Ratio = 2.71 (Enterprise Value 44.6b / Total Assets 16.4b)
Interest Expense / Debt = 4.91% (Interest Expense 47.5m / Debt 967.0m)
Taxrate = 26.40% (1.19b / 4.51b)
NOPAT = 3.01b (EBIT 4.08b * (1 - 26.40%))
Current Ratio = 1.98 (Total Current Assets 10.9b / Total Current Liabilities 5.52b)
Debt / Equity = 0.10 (Debt 967.0m / totalStockholderEquity, last quarter 9.79b)
Debt / EBITDA = -0.60 (Net Debt -2.79b / EBITDA 4.64b)
Debt / FCF = -0.75 (Net Debt -2.79b / FCF TTM 3.73b)
Total Stockholder Equity = 10.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.57% (Net Income 3.31b / Total Assets 16.4b)
RoE = 31.76% (Net Income TTM 3.31b / Total Stockholder Equity 10.4b)
RoCE = 36.91% (EBIT 4.08b / Capital Employed (Equity 10.4b + L.T.Debt 634.0m))
RoIC = 29.32% (NOPAT 3.01b / Invested Capital 10.3b)
WACC = 8.56% (E(47.4b)/V(48.3b) * Re(8.66%) + D(967.0m)/V(48.3b) * Rd(4.91%) * (1-Tc(0.26)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 2.22 | Cagr: -1.60%
[DCF] Terminal Value 73.18% ; FCFF base≈3.90b ; Y1≈3.58b ; Y5≈3.18b
[DCF] Fair Price = 12.74 (EV 48.8b - Net Debt -2.79b = Equity 51.6b / Shares 4.05b; r=8.56% [WACC]; 5y FCF grow -10.06% → 2.50% )
EPS Correlation: 87.48 | EPS CAGR: 4.59% | SUE: 0.97 | # QB: 1
Revenue Correlation: 97.68 | Revenue CAGR: 3.39% | SUE: -3.33 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.21 | Chg30d=-0.86% | Revisions=+0% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.21 | Chg30d=-2.81% | Revisions=-43% | Analysts=6
EPS current Year (2027-03-31): EPS=0.83 | Chg30d=-0.17% | Revisions=-33% | GrowthEPS=-0.2% | GrowthRev=+8.6%
EPS next Year (2028-03-31): EPS=0.87 | Chg30d=-0.31% | Revisions=-11% | GrowthEPS=+5.0% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: -43%